Other Assets, Noncurrent of VERTEX PHARMACEUTICALS INC / MA from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Other Assets, Noncurrent in USD history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • VERTEX PHARMACEUTICALS INC / MA Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $1,098,000,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,098,000,000 +$107,800,000 +11% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,078,800,000 +$163,200,000 +18% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,007,300,000 +$131,600,000 +15% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $999,300,000 +$104,000,000 +12% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $990,200,000 +$515,000,000 +108% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $915,600,000 +$472,900,000 +107% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $875,700,000 +$448,200,000 +105% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $895,300,000 +$485,700,000 +119% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $475,200,000 +$342,700,000 +259% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $442,700,000 +$315,400,000 +248% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $427,500,000 +$316,800,000 +286% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $409,600,000 +$298,800,000 +270% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $132,500,000 +$56,982,000 +75% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $127,300,000 +$56,201,000 +79% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $110,700,000 +$61,438,000 +125% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $110,800,000 +$61,500,000 +125% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q3 2021 $75,518,000 -$296,772,000 -80% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $71,099,000 -$105,465,000 -60% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $49,262,000 -$111,373,000 -69% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $49,300,000 -$20,081,000 -29% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q3 2020 $372,290,000 +$292,305,000 +365% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $176,564,000 +$118,798,000 +206% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $160,635,000 +$121,594,000 +311% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $69,381,000 +$28,653,000 +70% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 $79,985,000 +$33,492,000 +72% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $57,766,000 +$25,115,000 +77% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $39,041,000 +$7,237,000 +23% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $40,728,000 +$13,332,000 +49% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 $46,493,000 +$35,951,000 +341% 30 Sep 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 $32,651,000 +$22,708,000 +228% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 $31,804,000 +$20,310,000 +177% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 $27,396,000 +$15,511,000 +131% 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q3 2017 $10,542,000 +$540,000 +5.4% 30 Sep 2017 10-Q 30 Oct 2017 2017 Q3
Q2 2017 $9,943,000 -$4,260,000 -30% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 $11,494,000 +$3,894,000 +51% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $11,885,000 +$4,973,000 +72% 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q3 2016 $10,002,000 -$1,059,000 -9.6% 30 Sep 2016 10-Q 31 Oct 2016 2016 Q3
Q2 2016 $14,203,000 +$5,067,000 +55% 30 Jun 2016 10-Q 01 Aug 2016 2016 Q2
Q1 2016 $7,600,000 -$352,000 -4.4% 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 $6,912,000 +$3,647,000 +112% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 $11,061,000 +$7,062,000 +177% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 $9,136,000 -$179,000 -1.9% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 $7,952,000 -$1,500,000 -16% 31 Mar 2015 10-Q 04 May 2015 2015 Q1
Q4 2014 $3,265,000 +$703,000 +27% 31 Dec 2014 10-K 16 Feb 2016 2015 FY
Q3 2014 $3,999,000 +$525,000 +15% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $9,315,000 +$5,028,000 +117% 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 $9,452,000 +$759,000 +8.7% 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 $2,562,000 -$7,106,000 -74% 31 Dec 2013 10-K 13 Feb 2015 2014 FY
Q3 2013 $3,474,000 -$6,919,000 -67% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $4,287,000 -$6,121,000 -59% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 $8,693,000 -$2,123,000 -20% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 $9,668,000 -$1,600,000 -14% 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q3 2012 $10,393,000 -$3,392,000 -25% 30 Sep 2012 10-Q 06 Nov 2012 2012 Q3
Q2 2012 $10,408,000 -$4,450,000 -30% 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 $10,816,000 -$4,907,000 -31% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $11,268,000 -$5,914,000 -34% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 $13,785,000 -$4,274,000 -24% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 $14,858,000 +$4,541,000 +44% 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q1 2011 $15,723,000 +$5,413,000 +53% 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 $17,182,000 31 Dec 2010 10-K 22 Feb 2012 2011 FY
Q3 2010 $18,059,000 30 Sep 2010 10-Q 28 Oct 2010 2010 Q3
Q2 2010 $10,317,000 30 Jun 2010 10-Q 03 Aug 2010 2010 Q2
Q1 2010 $10,310,000 31 Mar 2010 10-Q 03 May 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.